Skip to content Skip to sidebar Skip to footer

Healthcare Stocks

Island Pharmaceuticals
Island Pharmaceuticals (ASX:ILA) Raises A$9M as FDA Confirms Galidesivir Pathway: Is This Small-Cap Biotech a Buy?
Island Pharmaceuticals jumps after FDA backs galidesivir pathway Island Pharmaceuticals (ASX: ILA) surged as much as 23% to an intraday high of A$0.48 on Wednesday before settling at A$0.42, after delivering a dual catalyst that has significantly de-risked its lead drug program. The US Food and Drug Administration has confirmed the validity of the company's…
© 2026 Kicker. All Rights Reserved.

Add Your Heading Text Here